Juhayna Food Industries (JUFO)
Egyptian Exchange · Egypt · prices in EGP · close of 22 Oct 2026
Key indicators
| Last close | EGP 23.45 |
|---|---|
| 52-week range | 22.10 – 36.00 |
| Return, 1 month / 3 months | −13.2% / +1.4% |
| Return, 1 year / 3 years | +26.5% / +182.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 37 |
| Volatility (1 year) | 32.2% |
| Worst drawdown (1 year) | -21.9% |
| Average daily value traded | 31.70M EGP |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Juhayna Food Industries is an Egyptian company that makes dairy and juice products. It produces milk, yoghurt, flavoured dairy drinks and fruit juices, and it sells these under its own brands to households and retailers across Egypt. The company is based in Egypt and serves the domestic market through a distribution network that reaches shops and supermarkets. Its range also includes cheese and other dairy items, making it a familiar name in Egyptian kitchens and grocery aisles.
Juhayna Food Industries trades under the code JUFO on the Egyptian Exchange in Egypt, with its price quoted in Egyptian pounds (EGP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Juhayna Food Industries (JUFO) trades on the Egyptian Exchange in Egypt. It last closed at EGP 23.45 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 81 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.5% and over the last three months it rose 1.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.2% | ||
| From 52-week high | -30.4% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.4% | ||
| 6-month return | 2.7% | ||
| 12-month return, skipping the last month | 45.7% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.9% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 31.70M EGP | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −13.2% |
| 3 months | +1.4% |
| 6 months | +2.7% |
| 1 year | +26.5% |
| 3 years | +182.9% |
| 5 years | +596.2% |
Signals
| 50-day / 200-day average | 26.12 / 23.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | EGP 0.4000 |
| 8 Sep 2025 | EGP 0.3000 |
| 30 May 2024 | EGP 0.2000 |
| 6 Jun 2023 | EGP 0.1500 |
| 1 Nov 2022 | EGP 0.3500 |
| 3 Jan 2022 | EGP 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.